Publications & Talks
Our Research / Publications & Talks
Biomarkers for ALS Therapy Development.
Benatar M (invited speaker). Biomarkers for ALS Therapy Development. 5th Ottawa International Conference on Neuromuscular Disease and Biology. Ottawa, Canada, October 2019.
Biomarker Validation.
Benatar M (invited speaker). Biomarker Validation. Target ALS Annual Meeting. Boston, MA, May 2018.
ALS Therapy Development: Challenges and Opportunities.
Benatar M (invited speaker). ALS Therapy Development: Challenges and Opportunities. Platform presentation at the International Conference on Neuromuscular Disease. Toronto, Canada, July 2016.
Lessons for Charcot-Marie Tooth (CMT) Clinical Trials from ALS Experience.
Benatar M (invited speaker). Lessons for Charcot-Marie Tooth (CMT) Clinical Trials from ALS Experience. Inherited Neuropathic Consortium Annual Meeting. Miami, FL, January 2016.
Challenges and Opportunities in ALS Therapy Development.
Benatar M (invited speaker). Challenges and Opportunities in ALS Therapy Development. Ottawa International Conference on Neuromuscular Biology, Disease and Therapy. Ottawa, Canada, September 2015.
Challenges and Opportunities in ALS Therapy Development.
Flinders University Center for Neuroscience Seminar. Adelaide, Australia, September 2015.
Genetic Advances in ALS: Insights and Implications.
Benatar M (invited speaker). Genetic Advances in ALS: Insights and Implications. University of Iowa Annual Neurogenetics Meeting. Iowa City, IA, October 2015.
Challenges and Opportunities in ALS Therapy Development.
Benatar M (invited speaker). Challenges and Opportunities in ALS Therapy Development. Congress on Motor and Cognitive Degenerative Diseases. Yachay, Ecuador, January 2015.
ALS Therapy Development: Challenges and Opportunities.
Benatar M (invited speaker). ALS Therapy Development: Challenges and Opportunities. ALS Association Wisconsin Chapter. Milwaukee, WI, May 2014.
Pre-symptomatic loss of cerebral white matter integrity in those at genetic risk of amyotrophic lateral sclerosis.
Turner M (presenter), Filippini N, Govind V, Andersen PM, Stanislaw C, Reyes E, Hussain S, Wuu J, Benatar M. Pre-symptomatic loss of cerebral white matter integrity in those at genetic risk of amyotrophic lateral sclerosis. Platform presentation at the American Academy of Neurology 66th Annual Meeting, Philadelphia, PA, Apr 26 - May 3, 2014.
Year in Review: ALS.
Benatar M (invited speaker). Year in Review: ALS. American Academy of Neurology 65th Annual Meeting. San Diego, CA, March 2013.
Pre-Symptomatic Studies in ALS: Rationale, Challenges and Approach.
Benatar M (invited speaker). Pre-Symptomatic Studies in ALS: Rationale, Challenges and Approach. 12th Annual Packard Center Meeting. Baltimore, MD, March 2012.
Pre-fALS: Pre-Symptomatic Studies in ALS.
Benatar M (invited speaker). Pre-fALS: Pre-Symptomatic Studies in ALS. Workshop on Biomarker Studies in Pre-Symptomatic Carriers of Familial ALS/FTD. University of Oxford, Oxford, UK, January 2012.
Identifying Biomarkers in Familial ALS.
Benatar M (invited speaker). Identifying Biomarkers in Familial ALS. ALS Association Drug Discovery Meeting. Washington, DC, March 2012.
Piecing Together the Puzzle of ALS: An Emerging Picture.
Benatar M (invited speaker). Piecing Together the Puzzle of ALS: An Emerging Picture. Beijing International Conference on Neurology. Beijing, China, June 2012.